 The FDA has approved Xeris Pharmaceuticals Incs NASDAQ:XERS Gvoke Kit for severe hypoglycemia in pediatric and adult patients with diabetes ages two years and above. Gvoke Kit is the first ready-to-use glucagon available in a single-use vial and single-use syringe kit for rescue. 